Detalles de la búsqueda
1.
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study.
Future Oncol
; 19(23): 1601-1611, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37577810
2.
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?
Br J Cancer
; 127(5): 957-967, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35665778
3.
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials.
Eur J Cancer
; 184: 106-116, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36913832
4.
Total neoadjuvant treatment and organ preservation strategies in the management of localized rectal cancer: A narrative review and evidence-based algorithm.
Crit Rev Oncol Hematol
; 186: 103985, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059274
5.
Adverse events during first-line treatments for mCRC: The Toxicity over Time (ToxT) analysis of three randomised trials.
Eur J Cancer
; 189: 112910, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301718
6.
ShorTrip Trial: A Prospective, Multicentric Phase II Single-Arm Trial of Short-Course Radiotherapy Followed by Intensified Consolidation Chemotherapy With the Triplet FOLFOXIRI as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
Clin Colorectal Cancer
; 22(3): 339-343.e3, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429749
7.
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001711
8.
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial.
Front Oncol
; 13: 1307545, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38406172
9.
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients.
Cancers (Basel)
; 14(18)2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36139613
10.
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability.
Cancers (Basel)
; 14(20)2022 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291761
11.
Surgery combined with intra-operative microwaves ablation for the management of colorectal cancer liver metastasis: A case-matched analysis and evaluation of recurrences.
Front Oncol
; 12: 1023301, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36505851
12.
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer.
Eur J Cancer
; 165: 116-124, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35231767
13.
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
JCO Precis Oncol
; 6: e2200244, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36356286
Resultados
1 -
13
de 13
1
Próxima >
>>